Contact Us
China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical TrialSeptember 1, 2022
BEIJING, Aug. 30 (Xinhua) — A recent study has found that China's first self-developed HPV vaccine Cecolin can offer women adults full immunity against two types of human papillomavirus (HPV). A group of Chinese researchers analyzed data from 66-month follow-up visits as a part of the bivalent vaccine's Phase 3 clinical trial and found that its efficacy against high-grade genital lesions, typical symptoms of cervical cancer, reached 100 percent. Furthermore, the E coli-produced HPV 16/18 recombinant vaccine realized a 97 percent efficacy against persistent HPV infections, according to the study published in the journal Lancet Infectious Diseases. The clinical trial included 7,372 healthy women aged 18 to 45, with 3,689 in the vaccinated group and 3,683 in the control group. The cumulative incidence in the vaccinated group was noticeably lower than that in the control group, according to the study. Cecolin is jointly developed by Xiamen University and Xiamen Innovax, making China the third country in the world to attain an independent cervical cancer vaccine supply after the United States and the United Kingdom. It earned the World Health Organization Prequalification in October 2021.
(Source: Xinhua) 32.3KPlease understand that womenofchina.cn,a non-profit, information-communication website, cannot reach every writer before using articles and images. For copyright issues, please contact us by emailing: [email protected]. The articles published and opinions expressed on this website represent the opinions of writers and are not necessarily shared by womenofchina.cn. CommentsMagazinesProjects
Photos
Special Coverage |
Apple CEO says that he wants to increase investments in VietnamApple CEO says that he wants to increase investments in VietnamChina's Wang goes top in ITTF world rankingsKoke extends Atletico Madrid contract until 2025Tax Day 2024: Here's what to do if you can't pay your taxes by the deadlineChina's tourism industry witnesses surge in runGuardiola reveals fresh Man City injury blowNadal confirms comeback at Barcelona OpenTax Day 2024: Here's what to do if you can't pay your taxes by the deadlineDallas TikTok star Camryn Herriage speaks for the first time after hit